Details for New Drug Application (NDA): 021620
✉ Email this page to a colleague
The generic ingredient in MUCINEX DM is dextromethorphan hydrobromide; guaifenesin. There are twenty-three drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; guaifenesin profile page.
Summary for 021620
Tradename: | MUCINEX DM |
Applicant: | Rb Hlth |
Ingredient: | dextromethorphan hydrobromide; guaifenesin |
Patents: | 0 |
Pharmacology for NDA: 021620
Mechanism of Action | Sigma-1 Receptor Agonists Uncompetitive NMDA Receptor Antagonists |
Physiological Effect | Decreased Respiratory Secretion Viscosity Increased Respiratory Secretions |
Suppliers and Packaging for NDA: 021620
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MUCINEX DM | dextromethorphan hydrobromide; guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 021620 | NDA | ATLANTIC BIOLOGICALS CORP. | 17856-0056 | 17856-0056-1 | 1 TABLET, EXTENDED RELEASE in 1 PACKAGE (17856-0056-1) |
MUCINEX DM | dextromethorphan hydrobromide; guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 021620 | NDA | A-S Medication Solutions | 50090-1077 | 50090-1077-0 | 1 BLISTER PACK in 1 CARTON (50090-1077-0) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 60MG;1.2GM | ||||
Approval Date: | Apr 29, 2004 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 30MG;600MG | ||||
Approval Date: | Apr 29, 2004 | TE: | RLD: | Yes |
Expired US Patents for NDA 021620
Complete Access Available with Subscription